Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2023-04-03 2023-01-16
Drug Identification Number 02246599 02246599
Brand name PAMIDRONATE DISODIUM FOR INJECTION PAMIDRONATE DISODIUM FOR INJECTION
Common or Proper name PAMIDRONATE DISODIUM FOR INJECTION PAMIDRONATE DISODIUM FOR INJECTION
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients PAMIDRONATE DISODIUM PAMIDRONATE DISODIUM
Strength(s) 9MG 9MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 10mL 10mL
ATC code M05BA M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2023-01-09 2023-01-09
Estimated end date 2023-03-31 2023-03-31
Actual end date 2023-03-31
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Product is on 100% allocation. Product is on 100% allocation.
Health Canada comments